New COVID-19 Treatment Development Begins: Komipharm-Celivery Surge Followed by Disclosure!

- Found a company simultaneously holding ingredients for food/beverages, disinfectants, vaccines, and packaging! Check it out quickly!

- Once this company is known for COVID-19, it will 100% explode into a sold-out stock! Buy fast!

◈Found the biggest beneficiary stock of COVID-19! It's time to quickly buy the same materials as Komipharm_Celivery! ▶3-day free application◀

Research and development have begun to secure a vaccine manufacturing technology platform that can be quickly applied during a new infectious disease pandemic. Based on the technology developed for respiratory disease prevention vaccines such as the quadrivalent cell-cultured influenza vaccine and the 13-valent pneumococcal protein-conjugate vaccine, they aim to respond to new infectious diseases.

◈Development of a new drug that can cure COVID-19 100%! If a globally distributable vaccine comes out, it will soar! ▶3-day free application◀

The core of the platform technology is to have universality that allows rapid vaccine development through the same process even if a new variant virus of respiratory infectious disease appears, and to ensure high safety considering highly pathogenic viruses.

◈Vaccine development for respiratory infectious diseases speeds up with the same process! If "this" comes out, it will soar! ▶ Click here ◀

While the domestic pharmaceutical and bio industry, which had been struggling, is expected to show signs of recovery in the second half of this year, some stocks that had remained silent despite favorable factors are re-emerging, presenting a golden opportunity to aim for a life-changing breakthrough.

◈Are you just going to watch again? You must sweep up with COVID-19 now! Try investing even 1 million won! ▶3-day free application◀

※ Limited to the first 10 applicants! Recruiting the hero of the bottom of the 9th inning, 2 outs, walk-off grand slam ※

※ Limited to the first 10 applicants! Please understand early closure due to overwhelming applications. ※

[Today's stocks of interest]

Komipharm Celivery Prostemics PCL Kukdong

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.